Thomas Gabrielczyk - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Thomas Gabrielczyk's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Thomas Gabrielczyk
Verified
Chefredakteur / Editor in Chief, European Biotechnology
Berlin
Beats
Nutrition Sports Supplements and Powerlifting.Fitness Bodybuilding
Content
By Thomas Gabrielczyk Verified| European Biotechnology Verified MoonLake Immunotherapeutics (Zug, Switzerland) AG’s debt agreement with Hercules Capital Inc. includes an US$75m payment at signature adding to the company’s cash base of US$448m. Further debt tranches will be available upon achievement of pre-specified milestones. “We were able to secure deal terms, including a very sizeable commitment and a highly competitive cost of capital,” commented Matthias Bodenstedt, Chief Financial Officer at MoonLake Immunotherapeutics.
By Thomas Gabrielczyk Verified| European Biotechnology Verified The EU Commission’s bioeconomy strategy has to date centered on the utilisation of agricultural, forestry and industrial waste streams. However, a substantial raw material gap remains to be filled in order to fully transition from a fossil-based economy to bio-based solutions, as recently highlighted in presentations by the cabinet of the responsible Commissioner, Jessika Roswall.
By Thomas Gabrielczyk Verified| European Biotechnology Verified MoonLake Immunotherapeutics (Zug, Switzerland) AG’s debt agreement with Hercules Capital Inc. includes an US$75m payment at signature adding to the company’s cash base of US$448m. Further debt tranches will be available upon achievement of pre-specified milestones. “We were able to secure deal terms, including a very sizeable commitment and a highly competitive cost of capital,” commented Matthias Bodenstedt, Chief Financial Officer at MoonLake Immunotherapeutics.
Company Info
European Biotechnology
European Biotechnology Magazine is a prominent English-language publication that reports on scientific, political, and economic developments in biotechnology and life sciences across Europe. Established in 2002, it covers 27 EU countries, Switzerland, Great Britain, and Norway, providing in-depth analysis and regional news from various parts of Europe. The magazine offers comprehensive stock market information, including updates on share prices of European biotech companies listed on stock exchanges. It serves a diverse audience, including biotech, pharmaceutical, and academic researchers, as well as industry leaders and organizations. European Biotechnology Magazine is recognized as the official media partner of the Society for Laboratory Automation & Screening (SLAS), highlighting its role in the biotech community. It covers emerging trends in the industry, making it a valuable resource for professionals in the field.
Berlin, Germany
+49 30 2649210
Founded: 2000